Research Article
Does Pharmacological Treatment Reduce the Incidence of Lower Urinary Tract Symptoms (LUTS) after Transobturator Sling?
Table 1
Demographic characteristics of patients groups.
| | Variable | Control group
(n=110) | Treatment group 1
(10 mg of solifenacin)
(n=114) | Treatment group 2
(50 mg of mirabegron)
(n=104) |
| | Age (years) | 55.5 (±11.3) | 54.6 (±13.1) | 53.6 (±12.2) |
| | BMI (kg/m2) | 27.3 (±3.3) | 27.0 (±3.7) | 26.8 (±4.2) |
| Postmenopausal
n, (%) | 73 (66.4) | 69 (60.5) | 61 (58.7) |
| | Parity | 1.9 (±1.0) | 1.9 (±1.0) | 1.7 (±1.2) |
|
|
There was no statistically significant difference between all investigated groups.
|
